Data / Form D filings / Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc.: Form D filing
Calidi Biotherapeutics, Inc., a biotechnology company in San Diego, CA, filed a Form D with the SEC in 2023. The latest, on June 29, 2023, reports $5 million sold of a $25 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4475 Executive Drive, Suite 200, San Diego, CA, 92121
- Phone
- (858) 794-9600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1758478
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2023 | New notice | $25,000,000 | $4,999,975 | $20,000,025 | 1 | Jun 20, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Allan Camaisa | Executive Officer, Director | |
| Heehyoung F. Lee | Director | |
| James F. Schoeneck | Director | |
| Alfonso F. Zulueta | Director | |
| Anthony F. Santidrian | Executive Officer | |
| Boris Minev | Executive Officer | |
| Stephen Thesing | Executive Officer | |
| Tony Kalajian | Executive Officer | |
| Amish F. Patel | Executive Officer | |
| David F. Sans | Executive Officer | |
| Wendy Pizarro | Executive Officer | |
| Scott F. Leftwich | Director | |
| George Ng | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 26, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Calidi Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.